Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

peptides

  • You have access
    Correlation of 68Ga-RM2 PET with Post-Surgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
    Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
    Journal of Nuclear Medicine May 12, 2022, jnumed.122.263971; DOI: https://doi.org/10.2967/jnumed.122.263971
  • Open Access
    68Ga-DOTA-NT-20.3 Neurotensin receptor 1 positron emission tomography imaging as a surrogate for neuroendocrine differentiation of prostate cancer
    Wen Yu Wu, Fei Yu, Peng Jun Zhang, Ting Bu, Jing Jing Fu, Shu Yue Ai, Qin Qin You, Liang Shi, Guo Qiang Shao, Feng Wang, Marina Hodolic and Hong Qian Guo
    Journal of Nuclear Medicine February 17, 2022, jnumed.121.263132; DOI: https://doi.org/10.2967/jnumed.121.263132
  • Open Access
    Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer
    Alexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, Veronika Felber, Roswitha Beck, Francesco De Rose, Calogero D'Alessandria, Wolfgang Andreas Weber and Hans-Jürgen Wester
    Journal of Nuclear Medicine January 27, 2022, jnumed.121.263371; DOI: https://doi.org/10.2967/jnumed.121.263371
  • Open Access
    Substitution of L-Trp by α-methyl-L-Trp in 177Lu-RM2 results in 177Lu-AMTG, a high affinity GRPR ligand with improved in vivo stability
    Thomas Guenther, Sandra Deiser, Veronika Felber, Roswitha Beck and Hans-Juergen Wester
    Journal of Nuclear Medicine January 13, 2022, jnumed.121.263323; DOI: https://doi.org/10.2967/jnumed.121.263323
  • You have access
    Affibody-mediated PNA-based pretargeted co-treatment improves survival of trastuzumab-treated mice bearing HER2-expressing xenografts
    Maryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva, Yongsheng Liu, Olga Vorontsova, Tianqi Xu, Kristina Westerlund, Anna Orlova, Vladimir Tolmachev and Amelie Eriksson Karlström
    Journal of Nuclear Medicine October 28, 2021, jnumed.121.262123; DOI: https://doi.org/10.2967/jnumed.121.262123
  • Open Access
    αvβ6-Targeted Molecular PET/CT Imaging of the Lungs After SARS-CoV-2 Infection
    Cameron C. Foster, Ryan A. Davis, Sven H. Hausner and Julie L. Sutcliffe
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1717-1719; DOI: https://doi.org/10.2967/jnumed.120.255364
  • You have access
    Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT
    Frederik L. Giesel, Leon Will, Claudia Kesch, Martin Freitag, Christophe Kremer, Jonas Merkle, Oliver C. Neels, Jens Cardinale, Boris Hadaschik, Markus Hohenfellner, Klaus Kopka, Uwe Haberkorn and Clemens Kratochwil
    Journal of Nuclear Medicine April 1, 2018, 59 (4) 632-635; DOI: https://doi.org/10.2967/jnumed.117.196329
  • You have access
    Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
    Lisa Bodei, Valentina Ambrosini, Ken Herrmann and Irvin Modlin
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1718-1726; DOI: https://doi.org/10.2967/jnumed.116.186361
  • You have access
    The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
    Martin Barrio, Johannes Czernin, Stefano Fanti, Valentina Ambrosini, Ina Binse, Lin Du, Matthias Eiber, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine May 1, 2017, 58 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.116.185587
  • You have access
    Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important Organs
    Matthias Eder, Thomas Löhr, Ulrike Bauder-Wüst, Markus Reber, Walter Mier, Martin Schäfer, Uwe Haberkorn and Michael Eisenhut
    Journal of Nuclear Medicine August 1, 2013, 54 (8) 1327-1330; DOI: https://doi.org/10.2967/jnumed.112.114512
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire